Cys-C-cGMP

Cyclo(-Arg-Ala-Asp-D-Phe-Cys) trifluoroacetate salt

Cys(SO2NH2)

(2S)-N-[(2S)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-2-[[(2S)-2-[[(2R)-2-amino-3-sulfanylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]pentanediamide

L-Cysteine-3-13C

(Tyr0)-C-Type Natriuretic Peptide (32-53) (human, porcine, rat)

Dnp-Pro-Leu-Gly-Cys(Me)-His-Ala-D-Arg-NH2

2-(4-((3,4-dimethylphenyl)sulfonyl)piperazin-1-yl)-N-ethyl-6-methylpyrimidin-4-amine

1-(3-Methylsulfanylpropanoyl)pyrrolidine-2-carboxylic acid

4-(Benzo[d][1,3]dioxol-5-yl)butan-1-ol

2-[2-(4-Cyanophenyl)ethoxy]ethanol

N-ethyl-2-(4-((4-methoxyphenyl)sulfonyl)piperazin-1-yl)-6-methylpyrimidin-4-amine

2-(4-((4-ethoxyphenyl)sulfonyl)piperazin-1-yl)-N-ethyl-6-methylpyrimidin-4-amine

3-Pyrimidinecarboxylic acid, 6-(4-(dimethylamino)phenyl)-1-ethyl-1,4-dihydro-4-oxo-

Beta,beta-Dichloro-alpha-(trifluoromethyl)styrene

N-(5-tetrazolyl)-4-nitro-2-pyridinecarboxamide

6-methoxy-2,3-dihydro-1H-indene-5-sulfonamide